NeoVas Bioresorbable Coronary Scaffold First-in-Man Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bo Xu
Beijing Fuwai hospital, National center for cardiovascular diseases China
Principal Investigator - Guosheng Fu
Sir Run Run Shaw Hospital
Principal Investigator - Yaling Han, MD
The general hospital of Shenyang military region
Study Chair - Yao-Jun Zhang, PhD
Nanjing First Hospital, Nanjing Medical University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the General Hospital of Shenyang Military Region
Shenyang, Liaoning, China
- Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2014
- Primary completion
- 30 Nov 2014
- Completion
- 30 Sept 2019
- Last update posted
- 11 Apr 2016
- Registered enrollment
- 31
- Registry id
- NCT02195414
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.